Medifast, Inc.
MED
$13.40
$0.211.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.48M | -772.00K | 801.00K | 1.13M | -8.15M |
| Total Depreciation and Amortization | 4.05M | 3.28M | 12.38M | -6.00M | 3.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 925.00K | 2.67M | -13.25M | 12.76M | 19.14M |
| Change in Net Operating Assets | -10.83M | -1.77M | -4.88M | 1.18M | -983.00K |
| Cash from Operations | -3.38M | 3.41M | -4.95M | 9.07M | 13.07M |
| Capital Expenditure | -1.38M | -1.52M | -2.29M | -1.39M | -1.94M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.74M | -532.00K | -17.15M | -392.00K | -594.00K |
| Cash from Investing | 13.36M | -2.05M | -19.43M | -1.78M | -2.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -1.00K | -369.00K | -1.00K | -2.00K | -16.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.00K | -194.00K | 0.00 | -1.00K | -4.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.00K | -563.00K | -1.00K | -3.00K | -20.00K |
| Foreign Exchange rate Adjustments | -- | -- | 0.00 | 4.00K | 28.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.98M | 789.00K | -24.38M | 7.29M | 10.55M |